Pharmaceutical

Clinigen clears out cancer therapies in line with latest growth strategy

Following the business expansion in 2022, Clinigen announced the divestment of four of its cancer therapies.

Aug 12, 2023 - 20:00
Clinigen clears out cancer therapies in line with latest growth strategy
Following the business expansion in 2022, Clinigen announced the divestment of four of its cancer therapies.
Read the original article

Tags:

Previous Article

Oxurion unlocks $1m from Atlas for diabetic macular oedema therapy

Next Article

Sutro strengthens its immuno-oncology pipeline with two new ADCs

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

After failed FSGS bid, Travere wins full FDA approval for Filspari in IgAN

After failed FSGS bid, Travere wins full FDA approval f...

Sep 8, 2024

STAT+: With new acquisitions, Humana and CVS hope to turn members into patients

STAT+: With new acquisitions, Humana and CVS hope to tu...

Aug 3, 2023

STAT+: An inside look at PIPEs, the financing trend that has biotech abuzz

STAT+: An inside look at PIPEs, the financing trend tha...

Feb 29, 2024